Xermelo is indicated for the treatment of carcinoid syndrome diarrhoea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy.
MeSH: Carcinoid Tumor;Neuroendocrine Tumors
Group: Other alimentary tract and metabolism products